Arrayit Diagnostics has been operating separately from the parent company Arrayit since 2009 . They began seeking FDA approval for Ovadx by the end of 2010. Video from 2010 :
This PMA approval is much more stringent than the 510k. It is a 180 day process which could be prolonged in order to make a diagnostics test as 100% accurate as the scientists would like. AD has had plenty of time to gain FDA approval. An investor would assume to gain a commitment of 8million in funding from a 3rd party they would need FDA approval status for this upcoming Spinoff of Arrayit Diagnostics . Another variable to factor is the reverse merger which happened. You can visit www.otcshortreport.com and track a company's short volume. The last time ARYC had a significant jump in price was from $1.00 to $1.50. The shorts have made a killing betting against management who has never met a milestone since going public. Since ARYC has retired shares and made the float tiny , It is Redhotstocks.com's opinion that ARYC could experience a huge increase in PPS because of short covering which could lead to huge gains for investors. This would explain the 24 hour bashing of certain individuals on the yahoo message board who clearly have an intent to push the PPS lower for monetary gains. Remember to always do your DD and don't make trades based on what someone says on a message board.
For full disclosure Redhotstocks.com currently owns 27,727 shares of ARYC at an avg PPS of .21 . Redhotstocks.com may buy and sell ARYC in the next 6 months.